Global stem cell market

Stem Cell Market Size, Share, Growth Analysis, By Product(Adult stem cells (ASCs) (Hematopoietic, Mesenchymal, Neural, Epithelial/Skin), By Application(Regenerative medicines (Neurology, Orthopaedics, Oncology, Haematology), By Technology(Cell acquisition (Bone marrow harvest, Umbilical blood cord, Apheresis), Cell Production (Therapeutic cloning), By Therapy(Autologous, Allogenic), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35D2059 | Region: Global | Published Date: February, 2024
Pages: 275 | Tables: 138 | Figures: 77

Stem Cell Market Insights

Stem Cell Market size was valued at USD 11.83 Billion in 2019 and is poised to grow from USD 13.30 Billion in 2023 to USD 31.60 Billion by 2031, at a CAGR of 11.4% during the forecast period (2024-2031).

The global stem cell market is experiencing remarkable growth, driven by various factors and promising opportunities. The rising number of clinical trials and the growing adoption of stem cell therapies worldwide contribute significantly to market expansion. Additionally, in the context of COVID-19, government organizations, research institutes, and biotech and pharmaceutical firms are focusing on rapid and effective technologies for diagnosing and treating the disease. Stem cell therapies, such as mesenchymal stem cell-based immunomodulation treatment, have shown promise in treating COVID-19, leading to ongoing clinical trials. Positive results from these studies can pave the way for new therapies and fuel market growth. Furthermore, increased awareness about umbilical stem cells, growing demand for regenerative treatment options, and the pursuit of stem cell research and development initiatives are driving market growth. Companies are actively raising funds to develop stem cell-based therapies, highlighting the significant investments being made in this field. For example, Cellino Biotech raised USD 80 million to expand access to stem cell-based therapies and build a pioneering autonomous human cell foundry by 2031. The expanding applications of stem cell technologies and the higher adoption rates for these therapies globally are attracting increased investments from market players, further propelling the market growth.

Government initiatives that support research studies and provide funding also contribute to the market's expansion. Notably, the Australian Government allocated USD 5.9 million to finance eight medical research projects focused on developing innovative stem cell treatments for incurable diseases like leukemia, Parkinson's disease, and epilepsy. While the market offers substantial growth potential, certain challenges exist. Expensive procedures, regulatory complexities, and ethical considerations pose obstacles to market development. Despite these hindrances, the overall outlook for the global stem cell market remains optimistic, driven by the increasing demand for stem cell therapies, ongoing research and development efforts, and government support. As the market continues to evolve, businesses operating in the stem cell sector have the opportunity to capitalize on emerging trends and innovations, ultimately contributing to the advancement of healthcare and the betterment of patients' lives.

Stem cell research is a rapidly growing field that has the potential to revolutionize the treatment of various diseases and conditions. The market for stem cell research is expected to experience significant growth in the coming years due to factors such as the increasing prevalence of chronic diseases, rising investments in research and development, and growing demand for regenerative medicine. Additionally, technological advancements and the development of innovative stem cell therapies are expected to drive market growth. The market is highly competitive, with major players focusing on partnerships, collaborations, and mergers and acquisitions to expand their market presence. However, ethical concerns related to the use of stem cells and the high cost of stem cell therapies are expected to restrain market growth.

US Stem Cell Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Stem cells are important due to their regenerative potential, offering immense opportunities for treating diseases, injuries, and disorders by replacing damaged or dysfunctional cells with healthy ones, advancing medical research and personalized medicine.

Stem cell research is controversial due to ethical concerns surrounding the use of embryonic stem cells, which involve the destruction of human embryos. Additionally, debates arise regarding the potential misuse of stem cells, the complex nature of regulating the field, and religious or philosophical objections related to the beginning of human life.

Stem cells offer numerous benefits in various fields, including medicine and research. They have the potential to regenerate damaged tissues, treat diseases like cancer and genetic disorders, and improve understanding of human development. 

Stem cell treatments involve using undifferentiated cells to repair or replace damaged or diseased cells and tissues. These versatile cells can differentiate into various cell types, offering potential therapies for a range of medical conditions. 

Stem Cell Market size was valued at USD 11.83 Billion in 2019 and is poised to grow from USD 13.30 Billion in 2023 to USD 31.60 Billion by 2031, at a CAGR of 11.4% during the forecast period (2024-2031).

The stem cell market features a highly competitive landscape with the presence of numerous key players striving to gain a significant market share. These players are actively engaged in strategic initiatives such as mergers and acquisitions, partnerships, collaborations, and product launches to strengthen their position in the market. The prominent players in the market focus on expanding their product portfolios, investing in research and development activities, and leveraging advanced technologies to develop innovative stem cell therapies. Moreover, partnerships and collaborations with research institutions and healthcare organizations are key strategies employed by market players to accelerate the development and commercialization of stem cell-based therapies. 'Thermo Fisher Scientific (US)', 'Merck KGaA (Germany)', 'Lonza Group (Switzerland)', 'STEMCELL Technologies (Canada)', 'Takara Bio (Japan)', 'FUJIFILM Cellular Dynamics (US)', 'Sartorius AG (Germany)', 'GE Healthcare (UK)', 'Charles River Laboratories International (US)', 'Cynata Therapeutics (Australia)', 'Mesoblast (Australia)', 'Cellular Dynamics International (US)', 'Organogenesis (US)', 'Osiris Therapeutics (US)', 'Gamida Cell (Israel)', 'Pluristem Therapeutics (Israel)', 'Athersys (US)', 'Brainstorm Cell Therapeutics (Israel)', 'Cellectis (France)', 'Ncardia AG (Germany)'

The rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases is driving the demand for stem cell therapy. Stem cell transplant, stem cell injection, and stem cell treatment are increasingly being used as therapeutic options for these diseases. For instance, stem cell therapy for knees has gained popularity as a non-surgical option for treating knee pain caused by osteoarthritis. This increasing demand for stem cell therapy is expected to drive the growth of the stem cell market.

Growing Focus on Personalized Medicine: Personalized medicine is a growing trend in the stem cell market. Stem cell therapy for knees and other conditions is increasingly being personalized to meet the unique needs of individual patients. This involves the use of patient-specific stem cells to develop personalized treatments that are tailored to the patient's genetic makeup and medical history. This trend is being driven by advancements in stem cell research and technology, which are enabling the development of personalized stem cell therapies.

In terms of revenue, North America emerged as the leading market, capturing a substantial share in 2022. This can be attributed to the presence of innovators and key market players in the region, resulting in higher market penetration. The strong biotechnology industry, the presence of key players, extensive research and development activities, and the promotion of personalized medicines contribute to North America's market leadership. Additionally, the region benefits from government initiatives aimed at promoting stem cell therapies. For example, the government of Canada invested approximately USD 7 million in regenerative medicine and stem cell research in March 2020. This investment supports various transnational projects and clinical trials within the country, fostering the growth of the regenerative medicine sector.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global stem cell market

Product ID: SQMIG35D2059

$5,300
BUY NOW GET FREE SAMPLE